Reply to the Letter to the Editor

被引:0
作者
Melanie Kripp
Salah-Eddin Al-Batran
Ralf-Dieter Hofheinz
机构
[1] Universitätsmedizin Mannheim,III. Medizinische Klinik
[2] Universität Heidelberg,Institut für Klinisch
[3] Krankenhaus Nordwest,Onkologische Forschung
关键词
Gastric Cancer; Docetaxel; Triple Therapy; Folinic Acid; Primary Trial;
D O I
10.1007/s10120-015-0532-x
中图分类号
学科分类号
摘要
引用
收藏
页码:320 / 321
页数:1
相关论文
共 29 条
[1]  
Kripp M(2014)Quality of life of older adult patients receiving docetaxel-based chemotherapy triplets for esophagogastric adenocarcinoma: a randomized study of the Arbeitsgemeinschaft Internistische Onkologie (AIO) Gastric Cancer 17 181-187
[2]  
Al-Batran SE(2013)The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: a randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+) Eur J Cancer 49 835-842
[3]  
Rosowski J(2006)Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as firstline therapy for advanced gastric cancer: a report of the V325 Study Group J Clin Oncol 24 4991-4997
[4]  
Pauligk C(2007)Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study Group J Clin Oncol 25 3210-3216
[5]  
Homann N(1998)Interpreting the significance of changes in health-related quality-of-life scores J Clin Oncol 16 139-144
[6]  
Hartmann JT(undefined)undefined undefined undefined undefined-undefined
[7]  
Al-Batran SE(undefined)undefined undefined undefined undefined-undefined
[8]  
Pauligk C(undefined)undefined undefined undefined undefined-undefined
[9]  
Homann N(undefined)undefined undefined undefined undefined-undefined
[10]  
Hartmann JT(undefined)undefined undefined undefined undefined-undefined